// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

ABO Tolerance Following Treatment of Infant Mice with A-Expressing MHC-Identical Erythrocytes

J. Fersovich - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Evaluation of Coronary Artery Function during Normothermic Ex Situ Heart Perfusion

X. Qi - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Impact of Frailty on Survival in Patients Undergoing Advanced Therapies for Heart Failure

M. Stein - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

B Cells Drive Chronic Lung Allograft Rejection after Ischemia-Reperfusion Injury in Mouse Lung Transplantation

T. Watanabe - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ischemia-reperfusion injury

N/A

Host miRNA Profile of Invasive Aspergillosis in Lung Transplant Recipients

W. Gohir - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A Novel Tool to Quantify Immune Suppression after Pediatric Transplantation: Flow Cytometric Activation Assays

R.E. Penner - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Interferon Gamma

Clinical and Pathological Insights of Myocardial Molecular Profiling: Time to Revise ISHLT Grading System?

L. Potena - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Other

Acute cellular rejection

N/A

Long-Term Changes in Kidney Function after Left Ventricular Assist Device Implant: An Analysis of the STS Intermacs Database

D.D. Franz - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Donor Family and Recipient Anonymity: Time for Change

J. Poole - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Beta Receptor Blockade Fails to Recover Ventricular Function Despite Increased Pre-Synaptic Sympathetic Nervous System Function in Experimental Pulmonary Arterial Hypertension

J. Zelt - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

Carvedilol

5-Year Results from the ISHLT DCD Lung Transplant Registry Confirm Excellent Recipient Survival from Donation after Circulatory Death Donors

D.E. Van Raemdonck - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Donor-Recipient Size Matching via Chest X-ray Measurements and Primary Graft Dysfunction Risk in Lung Transplantation

D. Li - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Other

Primary graft dysfunction

N/A

Risk Factors for Cardiac Causes of Death in Males with Duchenne Muscular Dystrophy

C.A. Wittlieb-Weber - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Duchenne muscular dystrophy

N/A

ABO Incompatible Listing in Early Childhood Results in Earlier Transplantation and Equal Post-Transplant Survival Despite Predominant Use in Sicker Patients

S. Urschel - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Impact of Prolonging CMV Prophylaxis in High-Risk (CMV D+/R-) Lung Transplant Recipients

S. Herrera - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Cytomegalovirus infection

TA-9070

ISHLT Consensus on Standardization of Bronchoalveolar Lavage in Lung Transplantation

T. Martinu - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A Combination of Delayed Gastric Emptying and Gastroesophageal Reflux Disease is Associated with Worse Outcomes in Lung Transplantation

J. Fernandez-Castillo - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Gastroesophageal reflux disease

N/A

Outcome after Pulmonary Endarterectomy for Segmental Chronic Thromboembolic Pulmonary Hypertension

M. de Perrot - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic thromboembolic pulmonary hypertension

N/A

Correlation of Surgical and Computed Tomography Pulmonary Angiographic Level of Disease in Chronic Thromboembolic Pulmonary Hypertension

M.C. McInnis - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic thromboembolic pulmonary hypertension

N/A

HLA-G 14BP Polymorphism Matching Protects against Development of Post-Transplant Malignancy Following Heart Transplantation

M.B. Adamson - International Society for Heart & Lung Transplantation (ISHLT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Posttransplant malignancies

N/A

Copyright © 2026. QuantiNova All rights reserved